Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
+10.34%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$5.32B
AUM Growth
+$623M
(+13%)
Cap. Flow
+$354M
Cap. Flow
% of AUM
6.65%
Top 10 Holdings %
Top 10 Hldgs %
31.02%
Holding
1,573
New
308
Increased
332
Reduced
859
Closed
60
Top Buys
| 1 |
Equinix
EQIX
|
+$41.9M |
| 2 |
American Tower
AMT
|
+$33.5M |
| 3 |
CD
Chindata Group Holdings Limited American Depositary Shares
CD
|
+$28M |
| 4 |
Crown Castle
CCI
|
+$20.9M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$13.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$89.3M |
| 2 |
Microsoft
MSFT
|
+$66.1M |
| 3 |
Amazon
AMZN
|
+$63.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$26.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$25.2M |
Sector Composition
| 1 | Real Estate | 18.33% |
| 2 | Technology | 16.47% |
| 3 | Consumer Discretionary | 8.8% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Intellia Therapeutics
NTLA
$1.28B
| $134K | ﹤0.01% |
2,471
-208
| -8% | -$11.3K |
|
1177
Alnylam Pharmaceuticals
ALNY
$63.2B
| $133K | ﹤0.01% |
1,022
+184
| +22% | +$23.9K |
|
1178
Seres Therapeutics
MCRB
$200M
| $133K | ﹤0.01% |
+272
| New | +$133K |
|
1179
Sangamo Therapeutics
SGMO
$157M
| $133K | ﹤0.01% |
8,494
+594
| +8% | +$9.3K |
|
1180
Daktronics
DAKT
$856M
| $132K | ﹤0.01% |
28,311
+18,784
| +197% | +$87.6K |
|
1181
Twist Bioscience
TWST
$1.51B
| $131K | ﹤0.01% |
928
-1,012
| -52% | -$143K |
|
|
CLVS
1182
DELISTED
Clovis Oncology, Inc.
CLVS
| $131K | ﹤0.01% |
27,289
+11,738
| +75% | +$56.3K |
|
|
BPMC
1183
DELISTED
Blueprint Medicines
BPMC
| $129K | ﹤0.01% |
1,152
-350
| -23% | -$39.2K |
|
1184
Karyopharm Therapeutics
KPTI
$54.9M
| $129K | ﹤0.01% |
557
+138
| +33% | +$32K |
|
|
BHVN
1185
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $129K | ﹤0.01% |
+1,505
| New | +$129K |
|
1186
Civitas Resources
CIVI
$3.01B
| $128K | ﹤0.01% |
+6,636
| New | +$128K |
|
1187
Insteel Industries
IIIN
$754M
| $128K | ﹤0.01% |
5,767
-1,968
| -25% | -$43.7K |
|
1188
Fate Therapeutics
FATE
$111M
| $127K | ﹤0.01% |
1,398
-2,020
| -59% | -$184K |
|
|
WW
1189
DELISTED
WW International
WW
| $127K | ﹤0.01% |
5,209
-6,060
| -54% | -$148K |
|
|
DCPH
1190
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $127K | ﹤0.01% |
2,226
+288
| +15% | +$16.4K |
|
1191
Alkermes
ALKS
$4.7B
| $125K | ﹤0.01% |
+6,244
| New | +$125K |
|
|
ALLK
1192
DELISTED
Allakos
ALLK
| $125K | ﹤0.01% |
893
-506
| -36% | -$70.8K |
|
1193
Beam Therapeutics
BEAM
$2.02B
| $125K | ﹤0.01% |
+1,533
| New | +$125K |
|
1194
Ultragenyx Pharmaceutical
RARE
$3.04B
| $125K | ﹤0.01% |
905
-638
| -41% | -$88.1K |
|
1195
TruBridge
TBRG
$300M
| $125K | ﹤0.01% |
4,639
+1,574
| +51% | +$42.4K |
|
1196
PTC Therapeutics
PTCT
$4.52B
| $124K | ﹤0.01% |
2,031
-102
| -5% | -$6.23K |
|
1197
Iovance Biotherapeutics
IOVA
$858M
| $123K | ﹤0.01% |
2,645
-916
| -26% | -$42.6K |
|
1198
Allogene Therapeutics
ALLO
$253M
| $122K | ﹤0.01% |
4,830
+2,318
| +92% | +$58.6K |
|
|
MRTX
1199
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $122K | ﹤0.01% |
554
-472
| -46% | -$104K |
|
1200
FibroGen
FGEN
$45.1M
| $120K | ﹤0.01% |
129
+19
| +17% | +$17.7K |
|